Philip A. Berger
About
In The Last Decade
Philip A. Berger
89 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 129
- Cellular and Molecular Neuroscience 956
- Psychiatry and Mental health 863
- Cognitive Neuroscience 603
- Molecular Biology 565
- Pharmacology 452
Countries citing papers authored by Philip A. Berger
This map shows the geographic impact of Philip A. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Berger more than expected).
Fields of papers citing papers by Philip A. Berger
This network shows the impact of papers produced by Philip A. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Berger. The network helps show where Philip A. Berger may publish in the future.
Co-authorship network of co-authors of Philip A. Berger
This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. Berger. A scholar is included among the top collaborators of Philip A. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. Berger. Philip A. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Update on diagnostics for Phytophthora ramorum | 1 |
| 2 | 29 | |
| 3 | 37 | |
| 4 | 30 | |
| 5 | 1 | |
| 6 | 13 | |
| 7 | 10 | |
| 8 | 2 | |
| 9 | 18 | |
| 10 | Investigating opioid peptides in schizophrenia and depression. | 9 |
| 11 | 33 | |
| 12 | Mood disorders pharmacologic prevention of recurrences | 127 |
| 13 | 78 | |
| 14 | The anticholinergic intoxication syndrome: diagnosis and treatment. | 21 |
| 15 | Informed consent: psychotic patients and research. | 7 |
| 16 | 136 | |
| 17 | Investigating the role of endogenous opioid peptides in psychiatric disorders. | 8 |
| 18 | Mental health: progress and problems. | 2 |
| 19 | 6 | |
| 20 | Thyrotropin releasing hormone in depression and schizophrenia. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.